{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06241573",
            "orgStudyIdInfo": {
                "id": "1368-0130"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-508377-82-00",
                    "type": "REGISTRY",
                    "domain": "CTIS (EU)"
                },
                {
                    "id": "U1111-1300-2310",
                    "type": "REGISTRY",
                    "domain": "WHO International Clinical Trials Registry Platform (ICTRP)"
                }
            ],
            "organization": {
                "fullName": "Boehringer Ingelheim",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab",
            "officialTitle": "Lunsayil LTE: An Extension Trial Assessing Long-term Spesolimab Treatment in Patients With Hidradenitis Suppurativa (HS)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-test-long-term-treatment-with-spesolimab-in-people-with-a-skin-condition-disease-called-hidradenitis-suppurativa-hs-who-took-part-in-a-previous-study-with-spesolimab"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-16",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2030-04-17",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2030-04-17",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-29",
            "studyFirstSubmitQcDate": "2024-01-29",
            "studyFirstPostDateStruct": {
                "date": "2024-02-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-23",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Boehringer Ingelheim",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is open to people with hidradenitis suppurativa (HS) who have completed another study with spesolimab (study 1368-0098 (NCT05819398) or study 1368-0100).\n\nThe purpose of this study is to find out how well people tolerate spesolimab and whether it helps people with HS in the long-term. For about 1.5 years, participants get spesolimab injections under the skin every 2 weeks.\n\nParticipants are in the study for about 2 years. During this time, participants have 41 visits. 24 visits are done at the study site. 17 visits can be done by video call at the participant's home. At study visits, doctors check the severity of the participant's HS and collect information on any health problems of the participants."
        },
        "conditionsModule": {
            "conditions": [
                "Hidradenitis Suppurativa (HS)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2",
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 550,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Patients treated in Part I of parent trial 1368-0098 (NCT05819398)",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Spesolimab"
                    ]
                },
                {
                    "label": "Patients treated in Part II of parent trial 1368-0098 (NCT05819398)",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Spesolimab"
                    ]
                },
                {
                    "label": "Patients treated in parent trial 1368-0100",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Spesolimab"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Spesolimab",
                    "description": "Spesolimab",
                    "armGroupLabels": [
                        "Patients treated in Part I of parent trial 1368-0098 (NCT05819398)",
                        "Patients treated in Part II of parent trial 1368-0098 (NCT05819398)",
                        "Patients treated in parent trial 1368-0100"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Occurrence of treatment emergent adverse events (TEAE)",
                    "timeFrame": "up to 92 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Signed and dated written informed consent in accordance with ICH Harmonized Guideline for Good Clinical Practice (ICH-GCP) and local legislation prior to admission to the trial.\n2. Participants must be within the defined Residual Effect Period corresponding to 16 weeks since last spesolimab administration.\n3. Participants who have completed treatment in the parent hidradenitis suppurativa (HS) spesolimab trial (1368-0098 (NCT05819398) or 1368-0100) without premature discontinuation and are willing and able to continue treatment in this trial.\n4. Woman of childbearing potential (WOCBP) must be ready and able to use highly effective methods of birth control per ICH M3 (R2) that result in a low failure rate of less than 1% per year when used consistently and correctly.\n\nExclusion Criteria:\n\n1. Women who are pregnant, nursing, or who plan to become pregnant while in the trial.\n2. Use of any drug considered by the investigator likely to interfere with the safe conduct of the trial since the last visit of the parent trials.\n3. Use of immunomodulatory biologics or investigational agents since the last visit of the parent trials.\n4. Participants who require / intend to use certain restricted medications such as immunomodulatory biologics or other investigational drugs/devices during the course of the trial.\n5. Relevant chronic or acute infections including human immunodeficiency virus (HIV) and viral hepatitis. The corresponding laboratory tests will be performed at Visit 1. A participant can be re-screened if the participant was treated and is cured from the acute infection.\n\nFurther exclusion criteria apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Boehringer Ingelheim",
                    "role": "CONTACT",
                    "phone": "18002430127",
                    "email": "clintriage.rdg@boehringer-ingelheim.com"
                }
            ],
            "locations": [
                {
                    "facility": "Dermatology Research Associates",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Holdsworth House Medical Practice",
                    "status": "RECRUITING",
                    "city": "Sydney",
                    "state": "New South Wales",
                    "zip": "2010",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "1800271035",
                            "email": "australia@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.86785,
                        "lon": 151.20732
                    }
                },
                {
                    "facility": "SimcoDerm Medical and Surgical Dermatology Centre",
                    "status": "RECRUITING",
                    "city": "Barrie",
                    "state": "Ontario",
                    "zip": "L4M 7G1",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "18336022346",
                            "email": "canada@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.40011,
                        "lon": -79.66634
                    }
                },
                {
                    "facility": "Dr. S. K. Siddha Medicine Professional Corporation",
                    "status": "RECRUITING",
                    "city": "Newmarket",
                    "state": "Ontario",
                    "zip": "L3Y 5G8",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "18336022346",
                            "email": "canada@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.05011,
                        "lon": -79.46631
                    }
                },
                {
                    "facility": "HOP Priv\u00e9 Antony",
                    "status": "RECRUITING",
                    "city": "Antony",
                    "zip": "92160",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "0805102354",
                            "email": "france@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.75,
                        "lon": 2.3
                    }
                },
                {
                    "facility": "Fachklinik Bad Bentheim",
                    "status": "RECRUITING",
                    "city": "Bad Bentheim",
                    "zip": "48455",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "08007234742",
                            "email": "deutschland@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.30077,
                        "lon": 7.15767
                    }
                },
                {
                    "facility": "The University of Tokyo Hospital",
                    "status": "RECRUITING",
                    "city": "Tokyo, Bunkyo-ku",
                    "zip": "113-8655",
                    "country": "Japan",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "0120201230",
                            "email": "nippon@bitrialsupport.com"
                        }
                    ]
                },
                {
                    "facility": "Hospital of Lithuanian University of Health Sciences Kauno Klinikos",
                    "status": "RECRUITING",
                    "city": "Kaunas",
                    "zip": "50161",
                    "country": "Lithuania",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "80080099",
                            "email": "lithuania@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 54.90272,
                        "lon": 23.90961
                    }
                },
                {
                    "facility": "Hospital Pulau Pinang",
                    "status": "RECRUITING",
                    "city": "Georgetown Pulau Pinang",
                    "zip": "10990",
                    "country": "Malaysia",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "1800814353",
                            "email": "malaysia@bitrialsupport.com"
                        }
                    ]
                },
                {
                    "facility": "Hospital Kuala Lumpur",
                    "status": "RECRUITING",
                    "city": "Kuala Lumpur",
                    "zip": "50586",
                    "country": "Malaysia",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "1800814353",
                            "email": "malaysia@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 3.1412,
                        "lon": 101.68653
                    }
                },
                {
                    "facility": "National University Hospital",
                    "status": "RECRUITING",
                    "city": "Singapore",
                    "zip": "119074",
                    "country": "Singapore",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "8001207344",
                            "email": "singapore@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 1.28967,
                        "lon": 103.85007
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Related Info",
                    "url": "http://www.mystudywindow.com"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Once the criteria in section 'time frame' are fulfilled, researchers can use the following link https://www.mystudywindow.com/msw/datasharing to request access to the clinical study documents regarding this study, and upon a signed \"Document Sharing Agreement\". Furthermore, researchers can request access to the clinical study data, for this and other listed studies, after the submission of a research proposal and according to the terms outlined in the website.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "CSR"
            ],
            "timeFrame": "One year after the approval has been granted by major Regulatory Authorities and after the primary manuscript has been accepted for publication, or after termination of the development program.",
            "accessCriteria": "For study documents upon signing of a 'Document Sharing Agreement'. For study data 1. after the submission and approval of the research proposal (checks will be performed by the sponsor and/or the independent review panel, including checking that the planned analysis does not compete with sponsor's publication plan); 2. and upon signing of a legal agreement.",
            "url": "https://www.mystudywindow.com/msw/datasharing"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000017497",
                    "term": "Hidradenitis Suppurativa"
                },
                {
                    "id": "D000016575",
                    "term": "Hidradenitis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000013543",
                    "term": "Sweat Gland Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000017192",
                    "term": "Skin Diseases, Bacterial"
                },
                {
                    "id": "D000001424",
                    "term": "Bacterial Infections"
                },
                {
                    "id": "D000001423",
                    "term": "Bacterial Infections and Mycoses"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000012874",
                    "term": "Skin Diseases, Infectious"
                },
                {
                    "id": "D000013492",
                    "term": "Suppuration"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M19762",
                    "name": "Hidradenitis Suppurativa",
                    "asFound": "Hidradenitis Suppurativa",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18964",
                    "name": "Hidradenitis",
                    "asFound": "Hidradenitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16323",
                    "name": "Sweat Gland Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M19500",
                    "name": "Skin Diseases, Bacterial",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4722",
                    "name": "Bacterial Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M12136",
                    "name": "Mycoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M4721",
                    "name": "Bacterial Infections and Mycoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M15677",
                    "name": "Skin Diseases, Infectious",
                    "relevance": "LOW"
                },
                {
                    "id": "M16273",
                    "name": "Suppuration",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        }
    },
    "hasResults": false
}